CACLP - The largest IVD Expo & Conference

BC Platforms Teams With Negen for Consumer Genome Analysis

Industry news | 27 August, 2018 | CACLP
Finnish consumer genetic testing firm Negen has turned to BC Platforms for analysis of raw genomic data for clinical reporting purposes, the companies announced recently.

Under terms of the new partnership, BC Platforms will run data collected by Negen through its data management system to inform Negen's risk-scoring algorithms. Further terms were not disclosed.

Negen offers specific tests for diabetes and cardiovascular disease risk based on genomic and lifestyle factors. These tests, as well as a general screening for rare hereditary conditions, are intended to inform clinicians in recommending treatments and lifestyle changes, the company said.

"This partnership will greatly increase the awareness and utility of our genetic risk-scoring tools and our automatized genetic data interpretation," Negen CEO Kimmo Aro said in a statement.
Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference